Oxalyl chloride → HCID 71679221, compound

HRID 1469825Notes

Reaction equation

HRID 1469825 reaction equation
[CH3:1][C:2]1([CH3:24])[CH2:7][CH2:6][CH:5]([NH:8][C:9]2[C:18]3[C:13](=[C:14]([NH2:19])[CH:15]=[CH:16][CH:17]=3)[N:12]=[C:11]([C:20]([F:23])([F:22])[F:21])[N:10]=2)[CH2:4][CH2:3]1.[Cl:25][C:26]1[C:31]([C:32](O)=[O:33])=[C:30]([F:35])[C:29]([CH2:36][NH:37][C:38](=[O:43])[C:39]([CH3:42])([CH3:41])[CH3:40])=[CH:28][CH:27]=1.C(Cl)(=O)C(Cl)=O.CCN(C(C)C)C(C)C>CN(C=O)C.C(Cl)Cl>[Cl:25][C:26]1[C:31]([C:32]([NH:19][C:14]2[CH:15]=[CH:16][CH:17]=[C:18]3[C:13]=2[N:12]=[C:11]([C:20]([F:23])([F:21])[F:22])[N:10]=[C:9]3[NH:8][CH:5]2[CH2:4][CH2:3][C:2]([CH3:24])([CH3:1])[CH2:7][CH2:6]2)=[O:33])=[C:30]([F:35])[C:29]([CH2:36][NH:37][C:38](=[O:43])[C:39]([CH3:41])([CH3:40])[CH3:42])=[CH:28][CH:27]=1

Participants

7

Procedure

The title compound was prepared following the procedure described in Example-1 using N4-(4,4-dimethylcyclohexyl)-2-(trifluoromethyl)quinazoline-4,8-diamine (Intermediate-26, 100 mg, 0.295 mmol), 6-chloro-2-fluoro-3-(pivalamidomethyl)benzoic acid (Intermediate-2, 127 mg, 0.443 mmol), oxalyl chloride (84 mg, 0.66 mmol), DMF (1 drop) and DIPEA (115 mg, 0.89 mmol) in CH2Cl2 (3 mL) to afford 35 mg of the title product. 1H NMR (300 MHz, DMSO-d6): δ 10.30 (s, 1H), 8.67-8.65 (d, J=7.2 Hz, 1H), 8.59-8.56 (d, J=8.1 Hz, 1H), 8.22-8.16 (m, 2H), 7.74-7.68 (t, J=8.4 Hz, 1H), 7.45-7.33 (m, 2H), 4.32-4.30 (d, J=5.4 Hz, 2H), 4.14 (m, 1H), 1.76-1.66 (m, 4H), 1.43-1.24 (m, 4H), 1.14 (s, 9H), 0.99 (s, 3H), 0.95 (s, 3H); MS (m/z): 608.38 (M+H)+.

Workup

  1. customThe title compound was prepared

Sources & evidence

ORD record
ord-0bfe25b0b0c64d1f82d1757e10b55b1a
Source dataset
uspto-grants-2015_04
Patent number
US09006257B2

Reaction notes

Loading…